These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31559249)

  • 41. [Blistering autoimmune diseases of childhood].
    Goebeler M; Zillikens D
    Hautarzt; 2003 Jan; 54(1):14-24. PubMed ID: 12567253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.
    Segura S; Iranzo P; Martínez-de Pablo I; Mascaró JM; Alsina M; Herrero J; Herrero C
    J Am Acad Dermatol; 2007 Jun; 56(6):960-7. PubMed ID: 17368865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016.
    Schmidt E; Spindler V; Eming R; Amagai M; Antonicelli F; Baines JF; Belheouane M; Bernard P; Borradori L; Caproni M; Di Zenzo G; Grando S; Harman K; Jonkman MF; Koga H; Ludwig RJ; Kowalczyk AP; Müller EJ; Nishie W; Pas H; Payne AS; Sadik CD; Seppänen A; Setterfield J; Shimizu H; Sinha AA; Sprecher E; Sticherling M; Ujiie H; Zillikens D; Hertl M; Waschke J
    J Invest Dermatol; 2017 Jun; 137(6):1199-1203. PubMed ID: 28390814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Review of Acquired Autoimmune Blistering Diseases in Inherited Epidermolysis Bullosa: Implications for the Future of Gene Therapy.
    Patel PM; Jones VA; Behnam CT; Di Zenzo G; Amber KT
    Antibodies (Basel); 2021 May; 10(2):. PubMed ID: 34067512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current Clinical Trials in Pemphigus and Pemphigoid.
    Izumi K; Bieber K; Ludwig RJ
    Front Immunol; 2019; 10():978. PubMed ID: 31130959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease.
    Li Y; Foshee JB; Sontheimer RD
    J Am Acad Dermatol; 2011 Apr; 64(4):773-8. PubMed ID: 20494477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoimmune blistering skin diseases triggered by COVID-19 vaccinations: An Australian case series.
    Cowan TL; Huang C; Murrell DF
    Front Med (Lausanne); 2022; 9():1117176. PubMed ID: 36703892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Modern diagnostics of autoimmune bullous diseases].
    van Beek N; Schumacher N; Rose C; Schmidt E; Zillikens D
    Pathologe; 2020 Jul; 41(4):317-325. PubMed ID: 32542511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoimmune blistering diseases in children.
    Lara-Corrales I; Pope E
    Semin Cutan Med Surg; 2010 Jun; 29(2):85-91. PubMed ID: 20579597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A review of case-control studies on the risk factors for the development of autoimmune blistering diseases.
    Oh DD; Zhao CY; Murrell DF
    J Eur Acad Dermatol Venereol; 2016 Apr; 30(4):595-603. PubMed ID: 26434420
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens: differences in organ and species specificities and localization in chemically-separated human skin of three basement membrane antigens.
    Fine JD
    Coll Relat Res; 1985 Sep; 5(4):369-77. PubMed ID: 3902344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Autoantigens of subepidermal bullous autoimmune dermatoses].
    Georgi M; Jainta S; Bröcker EB; Zillikens D
    Hautarzt; 2001 Dec; 52(12):1079-89. PubMed ID: 11910857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New immunomodulating drugs in autoimmune blistering diseases.
    Korman NJ
    Dermatol Clin; 2001 Oct; 19(4):637-48, viii. PubMed ID: 11705351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ribosomal protein s6-ps240 is expressed in lesional skin from patients with autoimmune skin blistering diseases.
    Abreu-Velez AM; Googe PB; Howard MS
    N Am J Med Sci; 2013 Oct; 5(10):604-8. PubMed ID: 24350073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mucocutaneous features of autoimmune blistering diseases.
    Weinberg MA; Insler MS; Campen RB
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Nov; 84(5):517-34. PubMed ID: 9394385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New and emerging therapies in the treatment of blistering diseases.
    Korman NJ
    Dermatol Clin; 2000 Jan; 18(1):127-37, ix-x. PubMed ID: 10626118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis and clinical features of epidermolysis bullosa acquisita.
    Caux F
    Dermatol Clin; 2011 Jul; 29(3):485-91, x. PubMed ID: 21605816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoimmune and inherited subepidermal blistering diseases: advances in the clinic and the laboratory.
    Schmidt E; Zillikens D
    Adv Dermatol; 2000; 16():113-57; discussion 158. PubMed ID: 11094626
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita.
    Woodley DT; Briggaman RA; O'Keefe EJ; Inman AO; Queen LL; Gammon WR
    N Engl J Med; 1984 Apr; 310(16):1007-13. PubMed ID: 6369131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of autoimmune blistering disease, and specifically, pemphigus vulgaris, with cardiovascular disease and its risk factors: a systematic review and meta-analysis.
    Rokni AM; Ayasse M; Ahmed A; Guggina L; Kantor RW; Silverberg JI
    Arch Dermatol Res; 2023 Mar; 315(2):207-213. PubMed ID: 35262797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.